Laura Sheppard, MBA, MA

Sheppard 女士是全球申报高级总监兼医学作家，在合同研究组织和制药环境领域的文件质量控制、项目管理以及临床透明度和披露方面具有丰富经验。她拥有 20 年的转化科学、临床开发和临床业务经验，其中包括 15 年的医学写作和监管策略经验，涉及生物制剂和小分子的全球上市申请，以及新药临床试验申请 (IND) 和临床试验授权 (CTA) 申请。

Ms. Sheppard is serving her third consecutive term with the American Medical Writing Association as a Director-At-Large. Her experience in therapeutic areas includes anti-infectives, cardiovascular, central nervous system, endocrinology, gastrointestinal, immunology, nephrology, neurosciences, oncology, pain management, rare disease, respiratory, urology, and xenotransplantation.